Yoga for Breast Cancer

Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy Clinical Trial

Official title:

A Randomized Study of the Effect of Yoga in Patients With Breast Cancer Receiving Radiation Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01985945
• Other study ID #: UPCC 08113
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: December 31, 2015

Study information

• Verified date: March 2020
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: December 31, 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Stage I and II breast cancer patients undergoing active radiation therapy

• Above the age of 18

• Must sign informed consent form

• Must speak English

• Only women are eligible

Exclusion Criteria:

• Patients with medical restrictions that may interfere with yoga participation per their physicians' decision

• Those who have smoked in the last 6 months because smoking can interfere with the breathing and relaxation techniques of yoga.

• Those who have regularly taken yoga in the last 6 months, because they would not come to the intervention with the same baseline as other participants.

Related Conditions & MeSH terms

• Breast Neoplasms
• Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy

Intervention

Other:
• Yoga

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Adverse Events		One Year